Hochschulschrift
Targeting the first barrier in immune response: Design of novel TLR2 antagonists and binding mode investigation
- Weitere Titel
-
Modulation der ersten Barriere der Immunantwort: Design von TLR2-Antagonisten und Untersuchung ihrer Bindemodi
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Freie Universität Berlin, Diss., 2013
- Schlagwort
-
Arzneimittelentwicklung
Arzneimitteldesign
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Freie Universität Berlin
- (wann)
-
2013
- Urheber
- URN
-
urn:nbn:de:kobv:188-fudissthesis000000095470-8
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Murgueitio, Manuela S.
- Freie Universität Berlin
Entstanden
- 2013
Ähnliche Objekte (12)
Targeting the first barrier in immune response : design of novel TLR2 antagonists and binding mode investigation
Multivalently binding antagonists for the neurokinin-1 receptor
Targeting ion channels: development of novel antagonists and imaging tracers
Nanocapsules for targeting immune cells
Targeting of immune cells with trimannosylated liposomes
Editorial Overview: Molecular immunology : targeting the immune system
Targeting of RNA-binding proteins with macrocyclic peptides
Targeting lymph node stromal cells to induce immune tolerance
Targeting Subtype-Independent Immune Responses Against Influenza A Virus
Targeting intestinal epithelial barrier function to prevent onset of arthritis
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis
Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
Targeting the first barrier in immune response : design of novel TLR2 antagonists and binding mode investigation
Multivalently binding antagonists for the neurokinin-1 receptor
Targeting ion channels: development of novel antagonists and imaging tracers
Nanocapsules for targeting immune cells
Targeting of immune cells with trimannosylated liposomes
Editorial Overview: Molecular immunology : targeting the immune system
Targeting of RNA-binding proteins with macrocyclic peptides
Targeting lymph node stromal cells to induce immune tolerance
Targeting Subtype-Independent Immune Responses Against Influenza A Virus
Targeting intestinal epithelial barrier function to prevent onset of arthritis
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis
Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
Targeting the first barrier in immune response : design of novel TLR2 antagonists and binding mode investigation
Multivalently binding antagonists for the neurokinin-1 receptor
Targeting ion channels: development of novel antagonists and imaging tracers
Nanocapsules for targeting immune cells
Targeting of immune cells with trimannosylated liposomes
Editorial Overview: Molecular immunology : targeting the immune system
Targeting of RNA-binding proteins with macrocyclic peptides
Targeting lymph node stromal cells to induce immune tolerance
Targeting Subtype-Independent Immune Responses Against Influenza A Virus
Targeting intestinal epithelial barrier function to prevent onset of arthritis
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis